Related Experiment Video
Updated: Jun 14, 2026
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Phenylacetate induces growth inhibition and apoptosis of human osteosarcoma cells
Jong Hyuk Park1, Min Young Park, Ho Sung Park
1Department of Pathology, Chonbuk National University Medical School, Jeonju, Korea.
Purpose:
Phenylacetate has potent antiproliferative effects in many malignant tumors. However, the exact mechanism as to how phenylacetate induces cell growth arrest remains unclear and very little is known about its effects on human osteosarcoma cells. In this study, we investigated whether phenylacetate is effective against two osteosarcoma cell lines (HOS and U-2 OS) in vitro.
Materials And Methods:
The viability of phenylacetate-treated cell lines was assessed by trypan blue exclusion assay, and the cell cycle distribution was measured by flow cytometry. To measure cell apoptosis, poly (ADP-ribose) polymerase cleavage assay and flow cytometry were employed. The expressions of cell cycle-regulatory proteins and the apoptosis-related genes were evaluated by western blot analysis.
Results:
Phenylacetate was found to inhibit the growth of osteosarcoma cells, induce cell cycle arrest in the G1 phase, and induce apoptosis. A significant decrease in Bcl-2 expression and a mild up-regulation of Bax were also observed in both phenylacetate-treated cell lines. Reduced phosphorylation of the pRb and the increased expression of p21(Cip1) were observed subsequent to treatment with phenylacetate.
Conclusion:
These findings support the idea that phenylacetate may be an effective chemotherapeutic agent to be employed in the future against osteosarcoma, because phenylacetate acts to inhibit the growth of osteosarcoma cells through cell cycle arrest and apoptosis.
Insights
Phenylacetate inhibits osteosarcoma cell growth by inducing cell cycle arrest and apoptosis. This study investigated phenylacetate
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Phenylacetate exhibits antiproliferative effects in various cancers.
- The precise mechanism of phenylacetate-induced cell growth arrest is not fully understood.
- Limited data exists on phenylacetate's impact on human osteosarcoma.
Purpose of the Study:
- To investigate the efficacy of phenylacetate against human osteosarcoma cell lines (HOS and U-2 OS) in vitro.
- To elucidate the mechanism by which phenylacetate affects osteosarcoma cell growth, cell cycle, and apoptosis.
Main Methods:
- Cell viability assessed via trypan blue exclusion.
- Cell cycle distribution analyzed by flow cytometry.
- Apoptosis measured using poly (ADP-ribose) polymerase cleavage assay and flow cytometry.
- Expression of cell cycle-regulatory proteins and apoptosis-related genes evaluated by western blot analysis.
Main Results:
- Phenylacetate significantly inhibited osteosarcoma cell growth.
- Induced cell cycle arrest at the G1 phase and promoted apoptosis.
- Decreased Bcl-2 expression and mild Bax up-regulation observed.
- Reduced pRb phosphorylation and increased p21(Cip1) expression confirmed.
Conclusions:
- Phenylacetate demonstrates potential as an effective chemotherapeutic agent for osteosarcoma.
- Mechanism involves inhibition of cell growth via cell cycle arrest and apoptosis induction.
- Further research is warranted to explore clinical applications.
More Related Videos
08:07Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012